Corporate

Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Launches GLIPIQⓇ (Semaglutide) In India. Setting a new benchmark in affordability for GLP-1 therapy, with weekly treatment starting at ₹325. |SUBJECT: Press Release

Leave a Reply

Your email address will not be published. Required fields are marked *